Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

By Skedgel C.   Rayson D.   Dewar R.   Younis T.  

Breast Cancer Research and Treatment, Vol. 101, Iss. 3, 2007-03 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Correlation of Blood Sex Steroid Hormones with Body Size, Body Fat Distribution, and Other Known Risk Factors for Breast Cancer in Post‐Menopausal Chinese Women

By Boyapati Sonia M.  

Cancer Causes and Control, Vol. 15, Iss. 3, 2004-04 ,pp. : 305-311

Springer Publishing Company

Access to resources Recommend Favorite

NSAID use and survival after breast cancer diagnosis in post-menopausal women

By Blair Cindy   Sweeney Carol   Anderson Kristin   Folsom Aaron  

Breast Cancer Research and Treatment, Vol. 101, Iss. 2, 2007-01 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite

Association between common genetic variant of HRH2 and gastric cancer risk

By                            

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 497-503

Spandidos Publications

Access to resources Recommend Favorite

Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer

By Sabine Vicky  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 419-428

Springer Publishing Company

Access to resources Recommend Favorite